Product Name
CBLB Recombinant Rabbit Monoclonal Antibody [PSH03-49] - BSA and Azide free
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human CBLB aa 400-982 / 982.
Target Molecular Weight
Predicted band size: 109 kDa
Positive Control
Jurkat cell lysate, K-562 cell lysate, U-87 MG cell lysate, HeLa cell lysate, A431 cell lysate, A549 cell lysate, NIH/3T3 cell lysate, RAW264.7 cell lysate, PC-12 cell lysate, mouse lung tissue lysate, human stomach tissue.
Storage Instructions
Store at 2-8℃. Avoid freeze.
Purification Method
Protein A affinity purified.
Function
CBL-B is an E3 ubiquitin-protein ligase that in humans is encoded by the CBLB gene. CBLB is a member of the CBL gene family. CBL-B functions as a negative regulator of T-cell activation. CBL-B expression in T cells causes ligand-induced T cell receptor down-modulation, controlling the activation degree of T cells during antigen presentation.
Background References
1. Guo X et al. CBLB ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy. J Immunother Cancer. 2021 Mar
2. Wolf D et al. IFNγ Helps CBLB-Deficient CD8+ T Cells to Put Up Resistance to Tregs. Cancer Immunol Res. 2022 Apr
Synonyms
AI429560 antibody
AI851073 antibody
Cas Br M (murine) ecotropic retroviral transforming sequence b antibody
Casitas B lineage lymphoma b antibody
Casitas B lineage lymphoma proto oncogene b antibody
Casitas B-lineage lymphoma proto-oncogene b antibody
Cbl b antibody
CBLB antibody
CBLB_HUMAN antibody
DKFZp686J10223 antibody
Expand
AI429560 antibody
AI851073 antibody
Cas Br M (murine) ecotropic retroviral transforming sequence b antibody
Casitas B lineage lymphoma b antibody
Casitas B lineage lymphoma proto oncogene b antibody
Casitas B-lineage lymphoma proto-oncogene b antibody
Cbl b antibody
CBLB antibody
CBLB_HUMAN antibody
DKFZp686J10223 antibody
DKFZp779A0729 antibody
DKFZp779F1443 antibody
E3 ubiquitin protein ligase CBL B antibody
E3 ubiquitin-protein ligase CBL-B antibody
EC 6.3.2.- antibody
FLJ36865 antibody
FLJ41152 antibody
Nbla00127 antibody
RING finger protein 56 antibody
RNF56 antibody
SH3 binding protein CBL B antibody
SH3-binding protein CBL-B antibody
Signal transduction protein CBL B antibody
Signal transduction protein CBL-B antibody
Collapse
-
This data was developed using HA722008, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded human stomach tissue with Rabbit anti-CBLB antibody (HA722008) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA722008) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
This data was developed using HA722008, the same antibody clone in a different buffer formulation.
Western blot analysis of CBLB on different lysates with Rabbit anti-CBLB antibody (HA722008) at 1/2,000 dilution.
Lane 1: Jurkat cell lysate (20 µg/Lane)
Lane 2: K-562 cell lysate (20 µg/Lane)
Lane 3: U-87 MG cell lysate (20 µg/Lane)
Lane 4: HeLa cell lysate (20 µg/Lane)
Lane 5: A431 cell lysate (20 µg/Lane)
Lane 6: A549 cell lysate (20 µg/Lane)
Lane 7: NIH/3T3 cell lysate (20 µg/Lane)
Lane 8: RAW264.7 cell lysate (20 µg/Lane)
Lane 9: PC-12 cell lysate (20 µg/Lane)
Lane 10: Mouse lung tissue lysate (40 µg/Lane)
Exposure time: 24 seconds; ECL: K1802
Blocking: 5% NFDM/TBST, 1 hour at room temperature
Primary antibody: HA722008, 1/2,000 in 5% NFDM/TBST, overnight at 4 ℃
Secondary antibody: Goat anti-Rabbit IgG-HRP (HA1001), 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature
Predicted band size: 109 kDa
Observed band size: 109 kDa
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"